Evidence map›Paper›PMID 38534638›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Antimicrobial Resistance in Qatar: Prevalence and Trends before and Amidst the COVID-19 Pandemic.

Hassan Al Mana, Hamad Abdel Hadi, Godwin Wilson, Muna A Almaslamani, Sulieman H Abu Jarir, Emad Ibrahim, Nahla O Eltai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hassan Al ManaBiomedical Research Center, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0003-3259-2859
Hamad Abdel HadiCommunicable Diseases Centre, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.ORCID 0000-0001-8647-1695
Godwin WilsonLaboratory Medicine and Pathology, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.ORCID 0000-0003-0162-9591
Muna A AlmaslamaniCommunicable Diseases Centre, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.
Sulieman H Abu JarirCommunicable Diseases Centre, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.ORCID 0000-0002-6398-6423
Emad IbrahimBiomedical Research Center, Qatar University, Doha P.O. Box 2713, Qatar.
Nahla O EltaiBiomedical Research Center, Qatar University, Doha P.O. Box 2713, Qatar.
Hamad Medical Corporation · QAQatar University · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a global healthcare challenge with substantial morbidity, mortality, and management costs. During the COVID-19 pandemic, there was a documented increase in antimicrobial consumption, particularly for severe and critical cases, as well as noticeable travel and social restriction measures that might influenced the spectrum of AMR. To evaluate the problem, retrospective data were collected on bacterial infections and antimicrobial susceptibility patterns in Qatar before and after the pandemic from 1 January 2019 to 31 December 2021, covering 53,183 pathogens isolated from reported infection episodes. The findings revealed a significant resistance pattern for extended-spectrum beta-lactamase-producing

Indexed as

AMRbacterial co-infectionCOVID-19hospitalQatar

Identifiers

PMID38534638
PMCPMC10967570
OpenAlexW4391994749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.